Generic-Drug Makers Knock States' Objection To Sanctions

Law360 (May 5, 2021, 9:33 PM EDT) -- Generic-drug makers accused of participating in an industrywide price-fixing scheme are urging a Pennsylvania federal court to disregard state enforcers' objections to a special master's recommendation to sanction the California attorney general's office for failing to fulfill discovery obligations in the multidistrict litigation.

In a 10-page response brief slamming the attorneys general of Pennsylvania, Oregon and Minnesota, Teva Pharmaceuticals, Mylan and other drugmakers denied arguments that even though the proposed sanctions of barring certain evidence are directed solely at California, the scope of the penalties would hurt state enforcers in the case and potentially other plaintiffs if applied more broadly....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!